[HTML][HTML] Diagnosis and treatment of lipodystrophy: a step-by-step approach

D Araújo-Vilar, F Santini - Journal of endocrinological investigation, 2019 - Springer
Aim Lipodystrophy syndromes are rare heterogeneous disorders characterized by
deficiency of adipose tissue, usually a decrease in leptin levels and, frequently, severe …

[HTML][HTML] Clinical trials required to assess potential benefits and side effects of treatment of patients with anorexia nervosa with recombinant human leptin

J Hebebrand, G Milos, M Wabitsch, M Teufel… - Frontiers in …, 2019 - frontiersin.org
The core phenotype of anorexia nervosa (AN) comprises the age and stage dependent
intertwining of both its primary and secondary (ie, starvation induced) somatic and mental …

Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy

EA Oral, P Gorden, E Cochran, D Araújo-Vilar… - Endocrine, 2019 - Springer
Purpose To evaluate the effects of metreleptin in patients with partial lipodystrophy (PL).
Methods Patients aged≥ 6 months with PL, circulating leptin< 12.0 ng/mL, and diabetes …

[HTML][HTML] Congenital leptin deficiency and leptin gene missense mutation found in two Colombian sisters with severe obesity

H Yupanqui-Lozno, RA Bastarrachea… - Genes, 2019 - mdpi.com
Background: Congenital leptin deficiency is a recessive genetic disorder associated with
severe early-onset obesity. It is caused by mutations in the leptin (LEP) gene, which …

Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice

S Rockwood, D Mason, R Lord, P Lamar… - … and Obesity: Targets …, 2019 - Taylor & Francis
Purpose Diabetic obesity in the leptin-deficient ob/ob mouse is associated with weight gain,
and hyperglycemia, along with hyperinsulinemia. We have previously examined the effects …

GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans

AE Papathanasiou, E Nolen-Doerr… - European journal of …, 2019 - academic.oup.com
The discovery of leptin, an adipocyte-secreted hormone, set the stage for unraveling the
mechanisms dictating energy homeostasis, revealing adipose tissue as an endocrine …

[HTML][HTML] Congenital generalized lipodystrophy in Taiwan

RH Hsu, WD Lin, MC Chao, HP Hsiao, SL Wong… - Journal of the Formosan …, 2019 - Elsevier
Background Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by
scarce adipose tissue. This disease is distributed worldwide, but little is known about these …

The long-term management of congenital generalized lipodystrophy (Berardinelli-Seip syndrome): the clinical manifestations of Japanese siblings for approximately …

M Maeda, T Maeda, K Ebihara, K Ihara - Clinical Pediatric …, 2019 - jstage.jst.go.jp
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disease that is
characterized by loss of subcutaneous and visceral adipose tissues, and associated with …

[HTML][HTML] Lipodistrofias primarias: presentación clínica y diagnóstico

V Cortés, JL Santos - Revista médica de Chile, 2019 - SciELO Chile
Lipodistrofias primarias: presentación clínica y diagnóstico SciELO - Scientific Electronic Library
Online vol.147 número11 Entrenamiento físico en personas con enfermedad renal crónica …

[HTML][HTML] Metreleptin in lipodystrophy: a profile of its use

E Deeks - Drugs & Therapy Perspectives, 2019 - Springer
Abstract Metreleptin [Myalepta®(EU); Myalept®(USA)] is a recombinant analogue of human
leptin and currently the only drug available for the specific treatment of lipodystrophy (LD). In …